icon-folder.gif   Conference Reports for NATAP  
 
  The International Liver Congress™
EASL - European Association for the
Study of the Liver
June 23-26 2021
Back grey_arrow_rt.gif
 
 
 
Preclinical antiviral profile of AB-836, a potent, highly selective hepatitis B virus capsid inhibitor
 
 
  EASL International Liver Congress, June 23-26, 2021 JNJ-3989
 
N Mani1*, AG Cole1, SG Kultgen1, A Ardzinski1, T Chiu1, A Cuconati1, BD Dorsey1, K Fan1, I Graves1, J-T Guo2, TO Harasym1, Z Hu2,
R Kowalski1, J Kunta1, AM Lam1, ACH Lee1, B Liu1, E Mesaros1,
R Rijnbrand1, HMM Steuer1, K Stever1, S Tang1, X Teng1, EP Thi1, and MJ Sofia1
1Arbutus Biopharma; 2Blumberg Institute

0628211

0628212

0628213

0628214

0628215

0628216

0628217